Emerging Subspecialties in Neurology: Clinical Development.
Emerging Subspecialties in Neurology: Clinical development.
Filed under: Drug and Alcohol Rehabilitation
Neurology. 2013 Jan 1; 80(1): e4-7
Guptill JT, Dupuis RE, D’Cruz O
Therapeutic development includes the activities necessary to bring a new medicinal compound (chemical or biologic)… Continue reading
Drug and Alcohol Rehabilitation: Effects of Intracuff Dexamethasone on Post-Extubation Reactions.
Effects of intracuff dexamethasone on post-extubation reactions.
Filed under: Drug and Alcohol Rehabilitation
J Res Med Sci. 2012 Apr; 17(4): 338-43
Rafiei MR, Arianpour N, Rezvani M, Ebrahimi A
The most common complications after tracheal intubation during general anesthesia are sore throat, hoarseness, and laryngospasm which can cause severe discomfort to patients. Several methods have been suggested to prevent these complications. In this study, the effects of intracuff dexamethasone, lidocaine, and normal saline in reducing post-extubation reactions were compared.This double-blind clinical trial was performed on 180 men of ASA (American Society of Anesthesiologists) class I or II who underwent general anesthesia for elective inguinal herniation surgery in Imam Reza Hospital, Tehran, Iran during 2008-2010. Depending on the kind of drug used to fill the endotracheal tube (ETT) cuff, patients were randomly allocated into normal saline, lidocaine, and dexamethasone groups. Post-extubation reactions were then evaluated in all groups.The groups were demographically comparable. There were no significant differences between the three groups regarding post-extubation sore throat, hoarseness, or laryngospasm (p > 0.05). However, a significant difference in cough existed between the… Continue reading
Rehab Centers: Microsomal Prostaglandin E Synthase-1 Aggravates Inflammation and Demyelination in a Mouse Model of Multiple Sclerosis.
Microsomal prostaglandin E synthase-1 aggravates inflammation and demyelination in a mouse model of multiple sclerosis.
Filed under: Rehab Centers
Neurochem Int. 2012 Dec 21;
Takeuchi C, Matsumoto Y, Kohyama K, Uematsu S, Akira S, Yamagata K, Takemiya T
Microsomal… Continue reading
Depression Treatment: Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
Filed under: Depression Treatment
Eur Neurol. 2012 Dec 19; 69(3): 166-170
Rolet A, Magnin E, Millot JL, Berger E, Vidal C, Sileman G, Rumbach… Continue reading
Depression Treatment: Anxiety Disorders, Physical Illnesses, and Health Care Utilization in Older Male Veterans With Parkinson Disease and Comorbid Depression.
Anxiety Disorders, Physical Illnesses, and Health Care Utilization in Older Male Veterans With Parkinson Disease and Comorbid Depression.
Filed under: Depression Treatment
J Geriatr Psychiatry Neurol. 2012 Nov 29;
Qureshi SU, Amspoker AB, Calleo JS, Kunik ME, Marsh L… Continue reading
Longitudinal Relationship of Depressive and Anxiety Symptoms With Dyslipidemia and Abdominal Obesity.
Longitudinal Relationship of Depressive and Anxiety Symptoms With Dyslipidemia and Abdominal Obesity.
Filed under: Depression Treatment
Psychosom Med. 2012 Nov 28;
van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW
ObjectivePrevious research indicates that patients… Continue reading
Depression Treatment: Poor Sleep in Patients With Multiple Sclerosis.
Poor sleep in patients with multiple sclerosis.
Filed under: Depression Treatment
PLoS One. 2012; 7(11): e49996
Bøe Lunde HM, Aae TF, Indrevåg W, Aarseth J, Bjorvatn B, Myhr KM, Bø L
Poor sleep is a frequent symptom in patients with multiple sclerosis (MS). Sleep may be influenced by MS-related symptoms and adverse effects from immunotherapy and symptomatic medications. We aimed to study the prevalence of poor sleep and the influence of socio-demographic and clinical factors on sleep quality in MS- patients.A total of 90 MS patients and 108 sex-and age- matched controls were included in a questionnaire survey. Sleep complaints were evaluated by Pittsburgh Sleep Quality Index (PSQI) and a global PSQI score was used to separate good sleepers (?5) from poor sleepers (>5). Excessive daytime sleepiness, the use of immunotherapy… Continue reading